Azelastine, Fluticasone

Apo-Azelastine/Fluticasone

137 MCG / ACT + 50 MCG / ACT Spray (Metered-Dose)CanadaMarketedAuthorised 31 Oct 2023

In other countries

The same active substances on other registers, the same brand first.

DymistaBrazil · Viatris Farmaceutica do Brasil LtdaSame form
DymistaBrazil · Meda Pharma Importação e Exportação de Produtos Farmacêuticos Ltda.Same form
DYMISTA 137 micrograme/50 micrograme/dozaRomania · 137micrograme/50micrograme/doza · spray naz.,susp. · Meda Pharma GMBH & Co. KG.Same form
Duonase®Serbia · 50mcg/potisak+137mcg/potisak · sprej za nos, suspenzija · Actavis D.O.O. BeogradSame form
Dymista®Serbia · 50mcg/potisak+137mcg/potisak · sprej za nos, suspenzija · Viatris Healthcare D.O.O.Same form
Dymista®Serbia · 50mcg/potisak+137mcg/potisak · sprej za nos, suspenzija · Viatris Healthcare D.O.O.Same form
DymistaSaudi Arabia · Cipla LimitedSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Azelastine, Fluticasone

Apo-Azelastine/Fluticasone

137 MCG / ACT + 50 MCG / ACT Spray (Metered-Dose)CanadaMarketedAuthorised 31 Oct 2023

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dymista Nasal SpraySingapore · 0.1 %w/w + 0.0365 %w/w · spray, metered · Viatris Private Limited

Synaze Nasal SpraySingapore · 0.1 %w/w + 0.0365 %w/w · spray, metered · Viatris Private Limited

Azelastine Hydrochloride and Fluticasone PropionateUnited States · 0.137MG/SPRAY; 0.05MG/SPRAY · spray, metered · Apotex

DymistaUnited States · 0.137MG/SPRAY; 0.05MG/SPRAY · spray, metered · Mylan Speciality LP

Avancort Duo 137 Microgramos/50 Microgramos/Aplicacion Suspension Para Pulverizacion NasalSpain · 1 mg + 0,365 mg · suspensión para pulverización nasal · Laboratorios Cinfa S.A.

Azelastina/Fluticasona Teva 137 Microgramos/50 Microgramos/Aplicacion Suspension Para Pulverizacion NasalSpain · 0,989 mg/g + 0,361 mg/g · suspensión para pulverización nasal · Teva B.V.

Azerix 137 Microgramos/50 Microgramos/Aplicacion Suspension Para Pulverizacion NasalSpain · 0,137 mg + 0,05 mg · suspensión para pulverización nasal · Especialidades Farmaceuticas Centrum S.A.

AzefluxinItaly · Spray nasale, sospensione · Scharper S.P.A.

Azelastina e Fluticasone EgItaly · Spray nasale, sospensione · Eg S.P.A.

Azelastina e Fluticasone SubstipharmItaly · Spray nasale, sospensione · Substipharm

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Azelastine, Fluticasone
Strength: 137 MCG / ACT + 50 MCG / ACT
Dosage form: Spray (Metered-Dose)
Route: Nasal
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Oct 2023
Registration: DIN 02540886
Marketing authorisation holder: Apotex INC
ATC code: R01AD58
Group: Respiratory system
Supply: PRESCRIPTION